Literature DB >> 25354913

Genetic analysis of a case of glioblastoma with oligodendroglial component arising during the progression of diffuse astrocytoma.

Nobuhiro Hata1, Satoshi O Suzuki, Hideki Murata, Ryusuke Hatae, Yojiro Akagi, Yuhei Sangatsuda, Toshiyuki Amano, Koji Yoshimoto, Tomoko Tahira, Masahiro Mizoguchi.   

Abstract

The most recent definition of glioblastoma with oligodendroglioma component (GBMO) assigned clinical significance to the observation of oligodendroglial foci within glioblastomas. However, the pathological mechanism of its histogenesis has not yet been determined. We report the genetic analysis of a GBMO case that evolved from an astrocyte lineage. A 37-year-old male underwent a third craniotomy for the removal of recurrent lesions of a secondary glioblastoma originating from a previous diffuse astrocytoma. The lesion in the right frontal lobe contained oligodendroglial foci within a glioblastoma background, while the remaining lesions showed only classic glioblastoma histology. Genetic analyses revealed distal 10q loss of heterozygosity (LOH) occurring de novo in the oligodendroglial tissue, as well as 10p, 17p LOH, and isocitrate dehydrogenase-1 gene (IDH1) mutations inherited from the previous lesions. The final recurrent glioblastoma underwent LOH on almost the entire of chromosome 10. Based on these results, the importance of an oligodendroglial component in glioblastomas may be limited.

Entities:  

Mesh:

Year:  2014        PMID: 25354913     DOI: 10.1007/s12253-014-9850-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  13 in total

1.  Molecular genetic alterations in glioblastomas with oligodendroglial component.

Authors:  J A Kraus; K Lamszus; N Glesmann; M Beck; M Wolter; M Sabel; D Krex; T Klockgether; G Reifenberger; U Schlegel
Journal:  Acta Neuropathol       Date:  2001-04       Impact factor: 17.088

2.  Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis.

Authors:  Nobuhiro Hata; Koji Yoshimoto; Nobuhiko Yokoyama; Masahiro Mizoguchi; Tadahisa Shono; Yanlei Guan; Tomoko Tahira; Yoji Kukita; Koichiro Higasa; Shinji Nagata; Toru Iwaki; Tomio Sasaki; Kenshi Hayashi
Journal:  Clin Chem       Date:  2006-01-05       Impact factor: 8.327

3.  Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.

Authors:  K Ichimura; E E Schmidt; A Miyakawa; H M Goike; V P Collins
Journal:  Genes Chromosomes Cancer       Date:  1998-05       Impact factor: 5.006

4.  DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.

Authors:  Hikaru Sasaki; Rebecca A Betensky; J Gregory Cairncross; David N Louis
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).

Authors:  Hideo Nakamura; Keishi Makino; Jun-ichi Kuratsu
Journal:  Brain Tumor Pathol       Date:  2011-06-01       Impact factor: 3.298

7.  The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology.

Authors:  Bernd W Scheithauer; Greg N Fuller; Scott R VandenBerg
Journal:  Brain Pathol       Date:  2008-07       Impact factor: 6.508

8.  Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases.

Authors:  Maurizio Salvati; Anna I Formichella; Alessandro D'Elia; Cristian Brogna; Alessandro Frati; Felice Giangaspero; Roberto Delfini; Antonio Santoro
Journal:  J Neurooncol       Date:  2009-04-03       Impact factor: 4.130

9.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Authors:  J G Cairncross; K Ueki; M C Zlatescu; D K Lisle; D M Finkelstein; R R Hammond; J S Silver; P C Stark; D R Macdonald; Y Ino; D A Ramsay; D N Louis
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

10.  Multiplexed analysis of post-PCR fluorescence-labeled microsatellite alleles and statistical evaluation of their imbalance in brain tumors.

Authors:  Koji Yoshimoto; Toru Iwaki; Takanori Inamura; Masashi Fukui; Tomoko Tahira; Kenshi Hayashi
Journal:  Jpn J Cancer Res       Date:  2002-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.